2021 July 20, 2021 Announcement of Commencement of Domestic Phase III Clinical Trial for Cytomegalovirus Endotheliitis June 30, 2021 We conducted a performance evaluation of a rapid SARS-CoV-2 antigen test kit using clinical samples. June 25, 2021 A component (glycogen/tetrapeptide-5) that suppresses fibroblast aging via stem cell exosomes, which are attracting attention in Regenerative medicine research, has been discovered. June 15, 2021 Initiation of Phase II Clinical Trial for Regenerative Medical Products Using Allogeneic Mesenchymal Stem Cells for Severe COVID-19 Pneumonia Patients June 2, 2021 The effect of eucalyptus oil on enhancing the skin's barrier function has been elucidated. April 23, 2021 The disinfectant effect of alcohol-based preparations against the novel coronavirus (SARS-CoV-2) has been confirmed. April 14, 2021 License Agreement with BioMimetics Sympathies for Novel Coronavirus Disease Treatment Candidate and R&D Organization "RB⁺" March 23, 2021 Announcement Regarding Acquisition of Olympus RMS Corporation's Stock (Transfer Agreement) March 18, 2021 The effectiveness of Goreisan (containing Atractylodes lancea) for weather-related headaches has been discovered. March 8, 2021 Announcement: Commencement of Domestic Phase II Clinical Trial of Janus Kinase Inhibitor "ROH-201" Previous123to the next